CambReg Partner with Leading Indian Based CRO

Cambridge Regulatory Services (CambReg) has formed a strategic alliance with SIRO Clinpharm, a leading global Indian based Clinical Research Organisation to provide pharma companies in both Asia and Europe

with both regulatory expertise and ability to conduct fast paced trials, according to the companies.

“This partnership will provide European pharma companies with increased confidence in accessing cost effective clinical trial solutions, hence introducing new clients to SIRO. In return SIRO will have the benefit of offering regulatory expertise through CamReg,” commented Karen James, Managing Director of Cambridge Regulatory Services.

"Our alliance with CambReg would go a long way in helping small and mid-sized companies cut through the regulatory maze in Europe," said Dr Chetan Tamhankar, Chief Operating Officer of SIRO Clinpharm. "This alliance builds on the strength of our European clinical trial operations and allows us to offer greater value to our clients," he added.

The new alliance will offer full regulatory services to pharma companies wishing to register human medicines, including new small molecule or biotech entities, Biologics, Herbals and Generics.